Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial

Our study shows the complexities of the current RMS risk stratification systems, emphasizing the need for a global consensus. A unified approach would reduce the risk of disparate treatments for similar patients and facilitate more straightforward cross-study comparisons.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2024-11-20
DOI
https://doi.org/10.1002/pbc.31436
Citations
7
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
2.93
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial

Johannes H. M. Merks, Raquel Hladun, Christine M. Heske, Julia Chisholm et al.
7 citations
Pediatric Blood & Cancer
Sarcoma Diagnosis and Treatment
2.93
article

Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical Trial

Johannes H. M. Merks, Raquel Hladun, Christine M. Heske, Julia Chisholm, Rajkumar Venkatramani, Meriel Jenney, Véronique Minard‐Colin, Josephine H. HaDuong, Gianni Bisogno, Andrea C. Ferrari, Ilaria Zanetti
article en
7 citations

Abstract

Our study shows the complexities of the current RMS risk stratification systems, emphasizing the need for a global consensus. A unified approach would reduce the risk of disparate treatments for similar patients and facilitate more straightforward cross-study comparisons.

Pediatric Blood & CancerVol. 72(2)
Universitat Autònoma de Barcelona (ES), National Institutes of Health (US), Children's Hospital of Orange County (US), Royal Marsden NHS Foundation Trust (GB), University of Padua (IT), Institute of Cancer Research (GB), Baylor College of Medicine (US), Utrecht University (NL), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), University Medical Center Utrecht (NL), Noah's Ark Children's Hospital for Wales (GB), Royal Marsden Hospital (GB), Princess Máxima Center (NL), National Cancer Institute (US), Children's Cancer Center (US), Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Good health and well-being
Openalex Percentile: Top 8%
Sarcoma Diagnosis and Treatment
2.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.